TrialBritish journal of cancer2012

Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II study.

A Roy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.